These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4226334)

  • 1. Antigenic variation in clones of Trypanosoma brucei. II. The drug-sensitivities of variants of a clone and the antigenic relationships of trypanosomes before and after drug treatment.
    Gray AR
    Ann Trop Med Parasitol; 1966 Sep; 60(3):265-75. PubMed ID: 4226334
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of Trypanosoma evansi to quinapyramine, suramin, stilbamidine and tryparsamide and analysis of cross-resistance.
    Gill BS
    Trans R Soc Trop Med Hyg; 1971; 65(3):352-7. PubMed ID: 4254332
    [No Abstract]   [Full Text] [Related]  

  • 3. Trypanosoma evansi: in vivo and in vitro determination of trypanocide resistance profiles.
    Zhang ZQ; Giroud C; Baltz T
    Exp Parasitol; 1993 Dec; 77(4):387-94. PubMed ID: 8253152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to drug by different isolates Trypanosoma evansi in China.
    Zhou J; Shen J; Liao D; Zhou Y; Lin J
    Acta Trop; 2004 May; 90(3):271-5. PubMed ID: 15099814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-interference silencing of the adenosine transporter-1 gene in Trypanosoma evansi confers resistance to diminazene aceturate.
    Witola WH; Inoue N; Ohashi K; Onuma M
    Exp Parasitol; 2004; 107(1-2):47-57. PubMed ID: 15208037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth rates of suramin-sensitive and resistant Trypanosoma evansi.
    Mutugi MW; Boid R; Luckins AG
    Trop Anim Health Prod; 1996 May; 28(2):147-50. PubMed ID: 8809977
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of trypanocidal arsenical drugs on Trypanosoma brucei and Trypanosoma rhodesiense.
    Flynn IW; Bowman IB
    Comp Biochem Physiol B; 1974 Jun; 48(2):261-73. PubMed ID: 4833120
    [No Abstract]   [Full Text] [Related]  

  • 8. A trypanosome oligopeptidase as a target for the trypanocidal agents pentamidine, diminazene and suramin.
    Morty RE; Troeberg L; Pike RN; Jones R; Nickel P; Lonsdale-Eccles JD; Coetzer TH
    FEBS Lett; 1998 Aug; 433(3):251-6. PubMed ID: 9744805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cloning and sub-cloning success rates in four stocks of Trypanosoma evansi and variation in suramin resistance of the clones.
    Mutugi MW; Boid R; Luckins AG
    Vet Parasitol; 1995 Dec; 60(3-4):213-20. PubMed ID: 8747904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug effects on the fine structure of Trypanosoma rhodesiense: suramin, tryparsamide and mapharside.
    Macadam RF; Williamson J
    Ann Trop Med Parasitol; 1974 Sep; 68(3):301-6. PubMed ID: 4280885
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of dihydronaphthofurandiones and dihydrofuroquinolinediones with trypanocidal activity and analysis of their stereoelectronic properties.
    Tapia RA; Salas C; Morello A; Maya JD; Toro-Labbé A
    Bioorg Med Chem; 2004 May; 12(9):2451-8. PubMed ID: 15080940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in the sensitivity to normal human serum of clone-derived antigenic variants of Trypanosoma (Trypanozoon) brucei complex trypanosomes.
    Rickman LR
    Med J Zambia; 1977; 11(2):41-2. PubMed ID: 878631
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species.
    Kaminsky R; Brun R
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2858-62. PubMed ID: 9797216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of suramin on Trypanosoma cruzi.
    Bisaggio DF; Adade CM; Souto-Padrón T
    Int J Antimicrob Agents; 2008 Mar; 31(3):282-6. PubMed ID: 18191547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of TAO expression on PCD-like phenomenon development and drug resistance in Trypanosoma brucei.
    Tsuda A; Witola WH; Konnai S; Ohashi K; Onuma M
    Parasitol Int; 2006 Jun; 55(2):135-42. PubMed ID: 16516538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transporter protein and drug resistance of Trypanosoma.
    Medina NP; Mingala CN
    Ann Parasitol; 2016; 62(1):11-5. PubMed ID: 27262952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
    Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
    Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma brucei: suramin and other trypanocidal compounds' effects on sn-glycerol-3-phosphate oxidase.
    Fairlamb AH; Bowman IB
    Exp Parasitol; 1977 Dec; 43(2):353-61. PubMed ID: 598447
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.